-
KLRB1 and IL12RB1 are pretherapeutic predictors of time to relapse in patients with psoriasis treated with IL-17 blockad
Author: Wang, Hailun; Zhang, Li; Xu, Xintian; Le, Yunchen; Cao, Han; Quan, Cheng; Xue, Feng; Hao, Pei; Pan, Meng; Li, Xia; Zheng, Jie; Chen, Lihong
Journal: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2026; Vol. 94, Issue 4, pp. 1158-1166. DOI: 10.1016/j.jaad.2025.11.081
-
Characterization and treatment outcomes of rituximab therapy in super-responders and rituximab-refractory pemphigus patients: A single-center retrospective stud
Author: Wu, Zhili; Jiang, Jiefeng; Duan, Keyun; Li, Guomin; Guo, Feng; Zhang, Jiao; Xue, Ruzeng
Journal: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2026; Vol. 94, Issue 4, pp. 1177-1183. DOI: 10.1016/j.jaad.2025.12.030
-
Sustaining treatment response in alopecia areata through tofacitinib dose tapering: A single-center retrospective stud
Author: Huang, Jundong; Jian, Jia; Li, Min; Ji, Ruxin; Tian, Tian; Liang, Xiaobing; Zhao, Zhixiang; Tang, Yan; Li, Ji; Liu, Fangfen; Shi, Wei
Journal: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2026; Vol. 94, Issue 4, pp. 1144-1150. DOI: 10.1016/j.jaad.2025.12.020
-
Advances and challenges in diagnostic strategies for HLRCC-A Letter to the Editor regarding the study by Ouchene et al on HLRC
Author: Zheng, Zunwen; Xie, Deqian; Lin, Yiling; Wu, Guangzhen
Journal: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2026; Vol. 94, Issue 4, pp. e257-e259. DOI: 10.1016/j.jaad.2025.09.114
-
Comment on Characterization and treatment outcomes of biologic therapy in super-responders and biologic-refractory psoriasis patient
Author: Yao, Guotai; Wang, Zhongzhi
Journal: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2026; Vol. 94, Issue 4, pp. e277-e277. DOI: 10.1016/j.jaad.2025.09.116
-
Artificial intelligence in dermatology: Ethical considerations from model selection to public administratio
Author: Yang, Xing-Yu; Chen, Mo
Journal: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2026; Vol. 94, Issue 4, pp. e301-e302. DOI: 10.1016/j.jaad.2025.10.167
-
Association of primary tumor location with all-cause and cancer-specific mortality in cutaneous malignant melanoma patient
Author: Wei, Shiyuan; Su, Licong; Wu, Liangzhi
Journal: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2026; Vol. 94, Issue 4, pp. 1116-1125. DOI: 10.1016/j.jaad.2025.11.027
-
Comments on Long-term, real-world effectiveness of adalimumab in the treatment of hidradenitis suppurativ
Author: Long, Qing; Li, Yan
Journal: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2026; Vol. 94, Issue 4, pp. e295-e296. DOI: 10.1016/j.jaad.2025.10.164
